切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2011, Vol. 07 ›› Issue (01) : 70 -73. doi: 10.3877/cma.j.issn.1673-5250.2011.01.020

综述

异位妊娠药物治疗研究进展
张佳丽   
  1. 400016 重庆, 重庆医科大学附属第二医院妇产科
  • 出版日期:2011-02-01

Progress on Pharmacotherapy of Ectopic Pregnancy

Jia-li ZHANG   

  1. Department of Gynecology and Obstetrics, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
  • Published:2011-02-01
引用本文:

张佳丽. 异位妊娠药物治疗研究进展[J]. 中华妇幼临床医学杂志(电子版), 2011, 07(01): 70-73.

Jia-li ZHANG. Progress on Pharmacotherapy of Ectopic Pregnancy[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2011, 07(01): 70-73.

近年异位妊娠(ectopic pregnancy,EP)的发病日趋年轻化,剖宫产率增加致剖宫产切口疤痕妊娠(cesarean scar pregnancy, CSP)显著增加,使异位妊娠的药物治疗,成为目前研究的热点。本文聚焦异位妊娠的药物治疗研究进展,旨在探索更为安全、简便、有效、低毒且能保留生育功能的异位妊娠治疗方法。

Currently, the patients suffered from ectopic pregnancy (EP) become younger day by day, the incidence of cesarean scar pregnancy (CSP) increased obviously as a result of the increase of cesarean section rate. Pharmacotherapy of ectopic pregnancy became a hot research.This article aims to make a summarize for the progress on pharmacotherapy of ectopic pregnancy and to search which method is more safety, convenient, effective, harmless and can keep future fertility.

1 C. Chandrasekhar. Ectopic pregnancy: A pictorial review[J].Clin Imag, 2008,32:468-473.
2 Carr RJ, Evans P. Ectopic pregnancy[J]. Prim Care, 2000,27:169-183.
3 Barnhart KT, Gosman G, Ashby R, et al. The medical management of ectopic pregnancy: A meta-analysis comparing " single dose" and " multidose" regimens[J]. Obstet Gynecol, 2003,101:778-784.
4 Alleyassin A, Khademi A, Aghahosseini M, et al. Comparison of success rates in the medical management of ectopic pregnancy with single-dose and multiple-dose administration of methotrexate: A prospective, randomized clinical trial[J]. Fertil Steril, 2006,85:1661-1666.
5 Lipscomb GH, Givens VA, Meyer NL,et al. Comparison of multidose and single-dose methotrexate protocols for the treatment of ectopic pregnancy[J]. Am J Obstet Gynecol,2005,192:1847-1848.
6 Guven ES, Dilbaz S. Comparison of the effect of single-dose and multiple-dose methotrexate therapy on tubal patency[J]. Fertil Steril,2007,88(5):1288-1292.
7 Menon S, Colins J, Barnhart KT. Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: A systematic review[J]. Fertil Steril, 2007,87:481-484.
8 Mol F, Mol BW, Ankum F, et al. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: A systematic review and meta-analysis[J]. Hum Reprod Update,2008,14(4): 309-319.
9 Hajenius PJ, Mol F, Mol BW, et al. Interventions for tubal ectopic pregnancy[J]. Cochrane Database Syst Rev, 200, (2): CD000324.
10 Da Costa Soares R, Elito J Jr, Camano L. Increment in beta-hCG in the 48-h period prior to treatment: A new variable predictive of therapeutic success in the treatment of ectopic pregnancy with methotrexate [J]. Arch Gynecol Obstet, 2008, 278(4): 319-324.
11 Lipscomb GH, Givens VA, Meyer NL, et al. Previous ectopic pregnancy as a predictor of failure of systemic methotrexate therapy[J]. Fertil Steril, 2004, 81: 1221-1224.
12 Bixby S, Tello R, Kuligowska E. Presence of a yolk sac on transvaginal sonography is the most reliable predictor of single-dose methotrexate treatment failure in ectopic pregnancy[J]. J Ultrasound Med, 2005, 24(5): 591-598.
13 Elito J Jr, Reichmann AP, Uchiyama MN, et al. Predictive score for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexate[J]. Int J Gynaecol Obstet, 1999, 67(2): 75-79.
14 Kahyaoglu S,Turgay I,Gocmen M, et al. A new predictive scoring system including shock index for unruptured tubal pregnancy patients[J].Eur J Obstet Gynecol Repred Biol, 2006, 126(1): 99-109.
15 Yang WL, Jia PY, Zhang YP, et al. Clinical scoring system for the treatment of ectopic pregnancy[J]. Matern Child Health Care China, 2008, 23(31): 4396-4397. [杨文兰,贾平英,张运平,等. 异位妊娠治疗临床评分[J]. 中国妇幼保健,2008, 23(31): 4396-4397.]
16 Song HD, Chen SL, He JX, et al. Combined use of methotrexate and mifepristone for ectopic pregnancy management: A meta-analysis [J]. J First Military Med Univ, 2006, 26(12): 1815-1817. [宋华东,陈士岭,何锦霞,等. 氨甲喋呤联合米非司酮治疗异位妊娠的Meta分析[J]. 南方医科大学学报,2006, 26(12): 1815-1817.]
17 Ocal P, Erkan S. Transvaginal ultrasound-guided aspiration and instillation of hyperosmolar glucose for treatment of unruptured tubal heterotopic pregnancy[J]. Arch Gynecol Obstet, 2007, 276(3): 386-389.
18 Smorgick N, Vaknin Z, Pansky M, et al. Combined local and systemic methotrexate treatment of viable ectopic pregnancy: Outcomes of 31 cases [J]. J Clin Ultrasound, 2008, 36(9): 1109-1112.
19 Vial Y, Petignat P, Hohlfeld P. Pregnancy in a cesarean scar [J]. Ultrasound Obstet Gynecol, 2000, 16(16): 592-593.
20 Seow KM, Huan LW, Lin YH, et al. Caesarean scar pregnancy: Issues in management [J]. Ultrasound Obstet Gynecol, 2004, 23(1): 247-253.
21 Maymon R, Halperin R, Mendlovic S, et al. Ectopic pregnancies in a caesarean scar: Review of the medical approach to an iatrogenic complication[J]. Hum Reprod Update, 2004, 10: 515-523.
22 Rotas MA, Haberman S, Levgur M. Cesarean scar ectopic pregnancies: Etiology, diagnosis and management[J]. Obstet Gynecol, 2006, 107: 1373-1377.
23 Hwu YM, Hsu CY, Yang HY. Conservative treatment of caesarean scar pregnancy with transvaginal needle aspiration of the embryo [J]. BJOG, 2005, 112: 841-842.
24 Muraji M, Mabuchi S, Hisamoto K. Cesarean scar pregnancies successfully treated with methotrexate [J]. Acta Obstet Gynecol Scand, 2009, 88(6): 678-682.
[1] 张曼, 李明庆, 李军苗. 当归四逆汤联合甲氨蝶呤治疗类风湿关节炎的疗效[J]. 中华关节外科杂志(电子版), 2023, 17(05): 648-652.
[2] 张振华, 侯俊, 赖建铭. 来氟米特联合甲氨蝶呤治疗幼年特发性关节炎的疗效[J]. 中华关节外科杂志(电子版), 2020, 14(04): 403-407.
[3] 何浈, 何翔, 郄明蓉. 输卵管妊娠患者发生持续性异位妊娠危险因素及早期诊断的倾向性评分匹配分析[J]. 中华妇幼临床医学杂志(电子版), 2020, 16(02): 181-187.
[4] 高秀, 尹如铁. 低危型妊娠滋养细胞肿瘤治疗热点[J]. 中华妇幼临床医学杂志(电子版), 2019, 15(02): 125-131.
[5] 肖卓妮, 杨菁, 徐望明. 剖宫产瘢痕妊娠治疗策略的临床疗效及并发症发生情况研究[J]. 中华妇幼临床医学杂志(电子版), 2019, 15(01): 31-38.
[6] 花茂方, 王媛, 姚军. 子宫肌壁间妊娠:宫腔镜及腹腔镜成功诊治一例并文献复习[J]. 中华腔镜外科杂志(电子版), 2019, 12(04): 250-252.
[7] 刘海元, 陈欣, 孙大为, 张俊吉, 冷金花, 朱兰, 刘珠凤, 樊庆泊, 史宏晖, 郎景和. 经阴道自然腔道内镜手术在异位妊娠中的应用八例分析[J]. 中华腔镜外科杂志(电子版), 2018, 11(01): 20-23.
[8] 栾兴龙, 苏峰, 程元星. 长期甲氨蝶呤治疗硫唑嘌呤干预无效型溃疡性结肠炎的临床研究[J]. 中华结直肠疾病电子杂志, 2018, 07(02): 141-144.
[9] 薛友余, 王伟, 陶勇, 冯婧. 玻璃体腔注射甲氨蝶呤治疗原发性眼内淋巴瘤的临床研究[J]. 中华眼科医学杂志(电子版), 2022, 12(02): 88-93.
[10] 王建爽, 张海静, 王雪松, 文颖, 周子敬. 不同预处理方式联合超声监测下清宫术治疗外生型CSP的疗效及安全性[J]. 中华介入放射学电子杂志, 2021, 09(04): 371-375.
[11] 郑国, 金钊, 齐静怡, 张芸. 输卵管妊娠后慢性输卵管炎的造影分析[J]. 中华介入放射学电子杂志, 2021, 09(01): 75-79.
[12] 吕益忠, 徐文健, 严冬华, 董淑蔷, 马永建, 王艳, 王晓静. 影响子宫动脉栓塞术在剖宫产疤痕妊娠中应用的因素分析[J]. 中华介入放射学电子杂志, 2018, 06(03): 199-203.
[13] 李奎, 颜国辉, 邹煜. 子宫动脉栓塞与甲氨蝶呤治疗不同MRI分型的剖宫产术后疤痕妊娠的疗效评价[J]. 中华介入放射学电子杂志, 2017, 05(03): 128-134.
[14] 雷红丹, 章灿辉, 袁运水. 输卵管黏膜容受性变化在输卵管妊娠发病中的作用[J]. 中华诊断学电子杂志, 2019, 07(04): 265-268.
[15] 汤斐, 赵云. 子宫动脉介入栓塞合并氨甲喋呤注射在胎盘完全滞留中的应用[J]. 中华卫生应急电子杂志, 2019, 05(03): 141-146.
阅读次数
全文


摘要